C. Kent Osborne

C. Kent Osborne is a Professor in the Department of Medicine (Hematology Oncology) at Baylor College of Medicine. He is the Founding Director of the Dan L Duncan Comprehensive Cancer Center and holds the Dudley and Tina Sharp Chair for Cancer Research. His clinical affiliation includes Baylor St. Luke's Medical Center. He received advanced training at the National Cancer Institute, completed a Medical Oncology residency at Johns Hopkins, and earned his M.D. from the University of Missouri-Columbia.

• Education:
  • Advanced Training: National Cancer Institute (1977)
  • Medical Oncology Residency: Johns Hopkins Hospital (1974)
  • M.D.: University of Missouri-Columbia School of Medicine (1972)
  • A.B. in Medicine: University of Missouri (1968)

His research focuses on breast cancer diagnosis and treatment, including resistance mechanisms to ER and HER2-targeted therapies. His work bridges molecular biology, clinical trials, and translational oncology. Recent studies include vitamin D3's role in aromatase inhibitor therapy, molecular biomarkers for treatment response, and consensus guidelines for early breast cancer management.

Leadership roles include directing the Dan L Duncan Cancer Center, which emphasizes multidisciplinary cancer research and patient care. Key grants include the NIH-funded Cancer Center Support Grant and SPORE in Breast Cancer. His clinical trials and publications highlight innovation in endocrine therapy, targeted drug combinations, and personalized medicine strategies.